This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 8 and 40
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Provided treatments

  • Drug: Ferumoxytol-enhanced magnetic resonance imaging
  • Device: Magentic Resonance Imaging

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02893293. The sponsor of the trial is Stanford University and it is looking for 20 volunteers for the current phase.
Official trial title:
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI